Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Si‐Man Huang"'
Autor:
Chao-Ling Wan, Yu-Qing Liu, Fang-Tong Liu, Yuan-Hong Huang, Han-Yu Cao, Si-Man Huang, Kai-Wen Tan, Shuai-Shuai Ge, Miao Wang, Mei-Jing Liu, Zi-Hao Wang, Zheng Li, Sheng-Li Xue, Hai-Ping Dai
Publikováno v:
Blood Cancer Journal, Vol 14, Iss 1, Pp 1-5 (2024)
Externí odkaz:
https://doaj.org/article/ba121fd695ca47baa50d149f14d7fca0
Autor:
Mei-Jing Liu, Lan Dai, Li Yao, Kai-Wen Tan, Han-Yu Cao, Si-Man Huang, Chao-Ling Wan, Yuan-Hong Huang, Yang Zhang, Wen-Jie Gong, Sheng-Li Xue
Publikováno v:
Haematologica, Vol 999, Iss 1 (2024)
Not available.
Externí odkaz:
https://doaj.org/article/9b491984e01c422fa237047dcd6ff9de
Autor:
Mei‐Jing Liu, Kai‐Wen Tan, Han‐Yu Cao, Si‐Man Huang, Chong‐Sheng Qian, Sheng‐Li Xue, Hai‐Ping Dai, Wen‐Jie Gong
Publikováno v:
HemaSphere, Vol 8, Iss 2, Pp n/a-n/a (2024)
Externí odkaz:
https://doaj.org/article/e67c1d859b3b44b58dbb7e4039eecb71
Autor:
Si‐Man Huang, Chao‐Ling Wan, Han‐Yu Cao, Yan‐Yan Li, Chong‐Sheng Qian, Hai‐Xia Zhou, Ming‐Zhu Xu, Xiao‐Hui Hu, Lan Dai, Hai‐Ping Dai, Sheng‐Li Xue
Publikováno v:
Clinical Case Reports, Vol 11, Iss 12, Pp n/a-n/a (2023)
Key Clinical Message There are no reports of application of inotuzumab ozogamicin (InO) for the treatment of MRD in r/r B‐ALL. We firstly report the efficacy of InO for a patient experienced morphological relapse after HSCT and molecular relapse af
Externí odkaz:
https://doaj.org/article/e00f4ab4696542c7889d7aed2a24ad24
Autor:
Jing-Ying Zou, Si-Man Huang, Hai-Xia Zhoub, Ming-Zhu Xu, Ai-Ning Sun, De-Pei Wu, Sheng-Li Xue, Tong-Tong Zhang
Publikováno v:
Hematology, Vol 28, Iss 1 (2023)
ABSTRACTObjectives: Venetoclax has shown synergism with BCR-ABL1 tyrosine kinase inhibitors (TKIs) in preclinical studies for patients with Philadelphia chromosome-positive (Ph+) leukemias. This combination may suggest a novel treatment strategy for
Externí odkaz:
https://doaj.org/article/f1cfee49a2964707ab25a52fd8865ca5
Autor:
Han-Yu Cao, Hui Chen, Song-Bai Liu, Wen-Jie Gong, Chong-Sheng Qian, Tong-Tong Zhang, Chao-Ling Wan, Si-Man Huang, Nan Xu, Hai-Ping Dai, Sheng-Li Xue
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
The treatment of B-cell acute lymphoblastic leukemia (B-ALL) with central nervous system (CNS) involvement poses a significant clinical challenge because most chemotherapeutic agents exhibit weak permeability to the blood-brain barrier (BBB). In addi
Externí odkaz:
https://doaj.org/article/26ca1df7ac334b7e82a4367e4326102c
Autor:
Si‐Man Huang, Tao Tao, Chao‐Ling Wan, Tian‐Mei Wu, Han‐Yu Cao, Yan Qiu, Xiang‐Dong Shen, Bin‐Ru Wang, Shuai‐Shuai Ge, Yan‐Yan Li, Tong‐Tong Zhang, Bing Wu, Sheng‐Li Xue
Publikováno v:
Clinical Case Reports, Vol 11, Iss 1, Pp n/a-n/a (2023)
Abstract Philadelphia chromosome‐positive acute myeloid leukemia (Ph + AML) is a rare type of AML with a low survival rate and poor prognosis. We first report a Ph + AML patient who remained in long‐term remission after the combination of flumati
Externí odkaz:
https://doaj.org/article/ed773244ff8842be89b88a44e8235d72
Autor:
Kai-Wen Tan, Yi-Yan Zhu, Qiao-Cheng Qiu, Man Wang, Hong-Jie Shen, Si-Man Huang, Han-Yu Cao, Chao-Ling Wan, Yan-Yan Li, Hai-Ping Dai, Sheng-Li Xue
Publikováno v:
Annals of Hematology.
Autor:
Lei-Si Zhang, Jun Wang, Ming-Zhu Xu, Tian-Mei Wu, Si-Man Huang, Han-Yu Cao, Ai-Ning Sun, Song-Bai Liu, Sheng-Li Xue
Publikováno v:
OncoTargets and Therapy. 15:159-164
Lei-Si Zhang,1,2,* Jun Wang,1,2,* Ming-Zhu Xu,1,2,* Tian-Mei Wu,1,2 Si-Man Huang,1,2 Han-Yu Cao,1,2 Ai-Ning Sun,1,2 Song-Bai Liu,3 Sheng-Li Xue1,2 1National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematolog